Primera Dx is categorized under Medical Research in Mansfield, MA and active since 2005.
Primera Dx was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6215120 by the NAICS.
If you are seeking more information, feel free to contact Matthew Mc Manus, Chief Executive Officer at the company’s single location by writing to 171 Forbes Boulevard, Mansfield, Massachusetts MA 02048 or by phoning (508) 618-2300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Primera Dx |
| Contact Person: | Matthew Mc Manus, Chief Executive Officer |
| Address: | 171 Forbes Boulevard, Mansfield, Massachusetts 02048 |
| Phone Number: | (508) 618-2300 |
| Website Address: | primerabio.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6215120 |
| Share This Business: |
Primera Dx was started in 2005 to provide professional Medical Research under the SIC code 8733 and NAICS code 6215120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Matthew Mc Manus, Chief Executive Officer for inquiries that concern Primera Dx by calling the company number (508) 618-2300, as your correspondence is most welcome. Additionally, the physical location of the single location of Primera Dx can be found at the coordinates 42.02924,-71.24165 as well as the street address 171 Forbes Boulevard in Mansfield, Massachusetts 02048.
For its online presence, you may visit Primera Dx’s website at primerabio.com and engage with its social media outlets through on Twitter and on Facebook.